| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/21/2001 | EP1084123A1 Novel asymmetrically substituted xanthine derivatives, method for producing them and their use as medicaments with an adenosine-antagonistic effect |
| 03/21/2001 | EP1084122A1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity |
| 03/21/2001 | EP1084109A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 03/21/2001 | EP1084104A1 Nitric oxide synthase inhibitors |
| 03/21/2001 | EP1084098A1 Inhibitors of the anandamide transporter as analgesic agents |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083913A1 Monoamine oxidase (mao) inhibitors and uses thereof |
| 03/21/2001 | EP1083909A1 hCEPR RECEPTOR |
| 03/21/2001 | EP1083904A2 Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol |
| 03/21/2001 | EP1083903A1 Bridged indenopyrrolocarbazoles |
| 03/21/2001 | EP1083902A1 Novel galenic formulations of meloxicam for oral administration |
| 03/21/2001 | EP1083898A1 Novel use of hiv protease inhibiting compounds |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083889A2 Method for treating neurodegenerative disorders |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/21/2001 | EP1083879A1 Methods and devices for providing prolonged drug therapy |
| 03/21/2001 | EP0762877B1 Meta substituted arylalkylamines and therapeutic and diagnostic uses thereof |
| 03/21/2001 | CN1288468A Antibodies against human IL-12 |
| 03/21/2001 | CN1288465A Triazolo-pyridzine derivatives as ligands for GABA receptors |
| 03/21/2001 | CN1288464A 4-(2-keto-1-benzimidazolynyl) pipeidine compounds as ORL-1 receptor |
| 03/21/2001 | CN1288383A St. John's wort and methyl donor composition and uses thereof |
| 03/21/2001 | CN1288382A Sea cucumber carotenoid lipid fraction products and method of use |
| 03/21/2001 | CN1288378A Celecoxib compositions |
| 03/21/2001 | CN1288375A TTS contg. an antioxidant |
| 03/21/2001 | CN1288007A 6-carbonyl-3-(4-[2-(pierid-1-yl)elhoyl]phenoxy)-2(4-methoxylphenyl) benzo[b]thiophene salt crystal |
| 03/21/2001 | CN1063436C Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines prepn. method and usage thereof |
| 03/21/2001 | CN1063430C Ethanolamine derivatives |
| 03/20/2001 | US6204292 Bicyclic metabotropic glutamate receptor ligands |
| 03/20/2001 | US6204261 Inhibitors of interleukin-1β Converting enzyme inhibitors |
| 03/20/2001 | US6204257 Drug delivery |
| 03/20/2001 | US6204241 Polypeptides found in vertebrate species, which polypeptides are mitogenic growth factors for glial cells, including schwann cells. |
| 03/20/2001 | US6204053 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6203796 Oregano-based therapeutic composition |
| 03/20/2001 | US6203792 Composition and methods using myelin-associated glycoprotein (MAG) and inhibitors thereof |
| 03/20/2001 | CA2206287C Aryl thioxanthines |
| 03/20/2001 | CA2199128C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 03/20/2001 | CA2132841C Aminocyclohexylamides for antiarrhythmic and anaesthetic uses |
| 03/20/2001 | CA2070169C Compounds with a sequence of three radicals, the central one being -aminoacidic and therapeutical applications thereof |
| 03/16/2001 | CA2317257A1 4-amino-1-aryl-1,5-dihydropyrrol-2-ones having anticonvulsant and anxiolytic activity and processes for their preparation |
| 03/15/2001 | WO2001018546A2 Screening for inhibitors of 'paired helical filaments' |
| 03/15/2001 | WO2001018236A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | WO2001018206A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | WO2001018204A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018169A2 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases |
| 03/15/2001 | WO2001018051A2 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 03/15/2001 | WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018043A2 Neurogenic compositions and methods |
| 03/15/2001 | WO2001018042A2 Apoptosis proteins |
| 03/15/2001 | WO2001018033A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018001A1 Pyrido-pyridazine derivatives as ligands for gaba receptors |
| 03/15/2001 | WO2001018000A1 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 03/15/2001 | WO2001017999A2 Amino-triazolopyridine derivatives |
| 03/15/2001 | WO2001017993A1 Alkylpiperidi nylbenzo [d] isoxazole derivatives having psychotropic activity, pharmaceutical compositions containing the same, and a process for the preparation of the active ingredient |
| 03/15/2001 | WO2001017989A2 Heteroaryloxypropanolamines as beta3-adrenergic receptor agonists |
| 03/15/2001 | WO2001017986A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | WO2001017963A2 Aminoalkoxy carbazoles and their use as 5-ht ligands |
| 03/15/2001 | WO2001017956A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/15/2001 | WO2001017953A1 Non-peptidic cyclophilin binding compounds and their use |
| 03/15/2001 | WO2001017614A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | WO2001017568A2 Bioconjugation in vivo to pulmonary or blood components |
| 03/15/2001 | WO2001017558A2 Novel uses of mammalian ccr6 receptors and related reagents |
| 03/15/2001 | WO2001017547A2 Bmp-9 compositions and methods for inducing differentiation of cholinergic neurons |
| 03/15/2001 | WO2001017545A1 Remedies for nervous diseases |
| 03/15/2001 | WO2001017532A1 Human neuropeptide receptor |
| 03/15/2001 | WO2001017472A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | WO2000071125A3 Pharmaceutical preparation containing the active substance diamorphine and its utilization in a method for treating opiate addiction |
| 03/15/2001 | WO2000071102A3 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders |
| 03/15/2001 | WO2000066732A3 Laminin 8 and methods for its use |
| 03/15/2001 | WO2000066614A8 3α-HYDROXY-3β METHOXYMETHYL-21-HETEROCYCLE SUBSTITUTED STEROIDS WITH ANESTHETIC ACTIVITY |
| 03/15/2001 | WO2000061609A3 Prodrugs of thrombin inhibitors |
| 03/15/2001 | WO2000061604A3 Pharmaceutical compounds |
| 03/15/2001 | WO2000051972A8 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy |
| 03/15/2001 | WO2000013648B1 Method for the preparation of citalopram |
| 03/15/2001 | DE19941217A1 Behandlung der Migräne durch Verabreichung von alpha-Liponsäure oder Derivaten derselben Treatment of migraine by administration of alpha-lipoic acid or derivatives thereof |
| 03/15/2001 | DE19940944A1 Retardierte, orale, pharmazeutische Darreichungsformen Prolonged-release oral pharmaceutical dosage forms |
| 03/15/2001 | DE19939044A1 Verwendung von Morphinanderivaten als Arzneimittel Use of morphinan derivatives as medicaments |
| 03/15/2001 | DE19925668A1 Spleißosomprotein und seine Verwendung Spleißosomprotein and its use |
| 03/15/2001 | DE19925073A1 Nucleinsäuremoleküle mit spezifischer Erkennung von nativem PrP·S··c·, Herstellung und Verwendung Nucleic acid molecules with specific detection of native PrP c · S · · ·, production and use |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2388562A1 Mammalian cytokines; related reagents and methods |
| 03/15/2001 | CA2386555A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | CA2384679A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384663A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | CA2384658A1 Neurogenic compositions and methods |
| 03/15/2001 | CA2384650A1 Apoptosis proteins |
| 03/15/2001 | CA2384099A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | CA2384083A1 Human neuropeptide receptor |
| 03/15/2001 | CA2384076A1 Novel uses of mammalian ccr6 receptors and related reagents |
| 03/15/2001 | CA2384051A1 Pyrido-pyridazine derivatives as ligands for gaba receptors |
| 03/15/2001 | CA2384048A1 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 03/15/2001 | CA2384006A1 A minimal tau peptide for the nucleation of paired helical filaments |
| 03/15/2001 | CA2383998A1 Amino-triazolopyridine derivatives |
| 03/15/2001 | CA2383798A1 Pulmonary delivery for bioconjugation |
| 03/15/2001 | CA2383794A1 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |